CAPTRUST Financial Advisors
ANGO icon

CAPTRUST Financial Advisors’s AngioDynamics ANGO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,019
Closed -$58K – 2154
2022
Q2 		$58K Buy
3,019
+136
+5% +$2.79K ﹤0.01% 2622
2022
Q1 		$62K Buy
2,883
+1,405
+95% +$31.9K ﹤0.01% 2627
2021
Q4 		$41K Sell
1,478
-309
-17% -$8.53K ﹤0.01% 2803
2021
Q3 		$46K Sell
1,787
-28
-2% -$749 ﹤0.01% 2625
2021
Q2 		$49K Sell
1,815
-15
-0.8% -$366 ﹤0.01% 2521
2021
Q1 		$43K Buy
1,830
+1,755
+2,340% +$35.5K ﹤0.01% 2520
2020
Q4 		$1K Buy
+75
New +$952 ﹤0.01% 3219

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

CAPTRUST Financial Advisors's ANGO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of AngioDynamics (ANGO) in Q3 2022, closing a stake of 3,019 shares — an estimated $58K sold.

CAPTRUST Financial Advisors first reported a position in ANGO in Q4 2020 and held it in 7 quarters. The position peaked at $62K in Q1 2022. 149 funds tracked by Wall St. Rank hold ANGO as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining AngioDynamics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3,019 AngioDynamics shares in Q3 2022, an estimated $58K.
  • CAPTRUST Financial Advisors first reported a position in AngioDynamics in Q4 2020 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's AngioDynamics position peaked at $62K in Q1 2022.
  • 149 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.